Press time:2016-11-14From:CR Pharma [ Font:BigMediumSmall]
China Resources Pharmaceutical Group (hereinafter: CR Pharma) released its 2015 CSR Report on November 14th, 2016. CR Pharma has released its CSR Report for 3 consecutive years. The report comprehensively and systematically introduces CR Pharma’s new progress in social responsibility on seven aspects, including responsibility management, customer responsibility, shareholder responsibility, partnership responsibility, employee responsibility, environmental responsibility and community responsibility.
In 2015, CR Pharma considered public health and product quality the top priority, focus on improving product quality and customer services; paid close attention to stakeholders’ needs in order to reach win-win results together; increased safety and environment input to fulfill its corporate social responsibility on green development; actively participated welfare events as reciprocation to the society. Under the joint efforts of all staff, CR Pharma’s total revenue achieved RMB￥116.6 billion and tax amount was RMB￥4.9 billion in 2015. Moreover, CR Pharma and its subsidiaries won several important awards including “the Second Prize of the National Science and Technology Progress Award”, “China Quality Award”, “2016 Top PRC nonprescription manufacturing enterprises”, “China AAA grade credit enterprise”, “Five-Star Enterprise in China CSR Index” and etc.
